Shanghai Zhongze Therapeutics Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Shanghai Zhongze Therapeutics Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Positron Emission Tomography (PET) Study to Evaluate Dopamine D2 and D3 Receptor Occupancy by SIPI6398 (NCT07626034) | Shanghai Zhongze Therapeutics Co., Ltd. | 2026-08-01 |
Track Shanghai Zhongze Therapeutics Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.